Canada markets closed

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.2000+0.0200 (+0.63%)
At close: 04:00PM EDT
3.2000 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
31,420
31,420
22,870
4,852
295.15
Selling General and Administrative
8,084
8,084
5,359
5,253
2,140
Total Operating Expenses
39,504
39,504
28,229
10,105
2,435
Operating Income or Loss
-39,504
-39,504
-28,229
-10,105
-2,435
Interest Expense
-
-
-
2.414
1,453
Total Other Income/Expenses Net
-239.216
-239.216
-194.709
1,591
-
Income Before Tax
-39,244
-39,244
-28,241
-8,516
-3,783
Income Tax Expense
16.949
16.949
20.777
6.004
0.8
Income from Continuing Operations
-39,261
-39,261
-28,261
-8,522
-3,783
Net Income
-39,261
-39,261
-28,261
-8,522
-3,783
Net Income available to common shareholders
-39,261
-39,261
-28,261
-8,522
-3,783
Basic EPS
-1.68
-
-1.45
-0.58
-1.24
Diluted EPS
-1.68
-
-1.45
-0.58
-1.24
Basic Average Shares
22,545
-
19,516
14,791
3,062
Diluted Average Shares
22,545
-
19,516
14,791
3,062